We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $133B
1-Year Est. Return 43.5%
This Fund
S&P 500
This Quarter Est. Return
+14.19%
1 Year Est. Return
+43.5%
3 Year Est. Return
+132.19%
5 Year Est. Return
+175.35%
10 Year Est. Return
+672.4%
AUM
$117B
AUM Growth
+$9.87B
Cap. Flow
-$1.11B
Cap. Flow %
-0.95%
Top 10 Hldgs %
30.52%
Holding
4,391
New
216
Increased
2,182
Reduced
1,537
Closed
202

Top Buys

Rank Stock Value
1
COF icon
Capital One
COF
+$89.2M
2
FLUT icon
Flutter Entertainment
FLUT
+$43.9M
3
OKTA icon
Okta
OKTA
+$32.1M
4
CHWY icon
Chewy
CHWY
+$31.8M
5
COIN icon
Coinbase
COIN
+$26.9M

Sector Composition

Rank Sector Weight
1 Technology 31.83%
2 Financials 13.86%
3 Consumer Discretionary 10.91%
4 Healthcare 9.41%
5 Industrials 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRML icon
3226
Critical Metals Corp
CRML
$968M
$95.2K ﹤0.01%
26,585
-16,462
-38% -$30K
SIEB icon
3227
Siebert Financial
SIEB
$81.8M
$94.9K ﹤0.01%
+21,476
New +$87.2K
CX icon
3228
Cemex
CX
$16.1B
$94.9K ﹤0.01%
13,694
-186
-1% -$1.18K
CNQ icon
3229
Canadian Natural Resources
CNQ
$97.3B
$94.7K ﹤0.01%
3,017
-1,065
-26% -$32.3K
NVCT icon
3230
Nuvectis Pharma
NVCT
$641M
$94.7K ﹤0.01%
+12,678
New +$115K
MAZE
3231
Maze Therapeutics
MAZE
$1.53B
$94.6K ﹤0.01%
7,714
+479
+7% +$4.98K
MKTAY
3232
DELISTED
MAKITA CORP SPONS ADR
MKTAY
$94K ﹤0.01%
3,024
+326
+12% +$10.1K
PROP icon
3233
Prairie Operating Co
PROP
$83.4M
$93.2K ﹤0.01%
31,134
+26,090
+517% +$104K
DMAC icon
3234
DiaMedica Therapeutics
DMAC
$372M
$93.2K ﹤0.01%
+23,894
New +$93.2K
CBNA
3235
Chain Bridge Bancorp
CBNA
$312M
$92.8K ﹤0.01%
+3,600
New +$90.5K
CRTO icon
3236
Criteo S.A. Ordinary Shares
CRTO
$870M
$92.7K ﹤0.01%
3,868
-40
-1% -$1.13K
ARM icon
3237
Arm
ARM
$308B
$92.3K ﹤0.01%
571
+403
+240% +$50K
EEX
3238
DELISTED
Emerald Holding
EEX
$92.3K ﹤0.01%
19,026
+1,644
+9% +$7.17K
FNWD icon
3239
Finward Bancorp
FNWD
$196M
$92.2K ﹤0.01%
+3,338
New +$98.6K
CXDO icon
3240
Crexendo
CXDO
$218M
$91.7K ﹤0.01%
+15,110
New +$78.9K
TLSI icon
3241
TriSalus Life Sciences
TLSI
$359M
$89.7K ﹤0.01%
+16,463
New +$88.3K
TUSK icon
3242
Mammoth Energy Services
TUSK
$159M
$89K ﹤0.01%
31,804
+7,757
+32% +$19.9K
BALY icon
3243
Bally's
BALY
$667M
$88.6K ﹤0.01%
+9,244
New +$108K
RCI icon
3244
Rogers Communications
RCI
$19.5B
$87.9K ﹤0.01%
2,963
FCEL icon
3245
FuelCell Energy
FCEL
$1.68B
$87.3K ﹤0.01%
15,570
-16,442
-51% -$79.8K
NL icon
3246
NLI Holdings
NL
$330M
$86.8K ﹤0.01%
13,563
+853
+7% +$6.43K
BSBR icon
3247
Santander
BSBR
$43.6B
$86.7K ﹤0.01%
15,917
+14,185
+819% +$72.4K
XPEV icon
3248
XPeng
XPEV
$11.2B
$86.6K ﹤0.01%
4,843
-143
-3% -$2.79K
AIRS icon
3249
AirSculpt Technologies
AIRS
$242M
$86.5K ﹤0.01%
17,906
-927
-5% -$3.15K
ISPR icon
3250
Ispire Technology
ISPR
$99.9M
$86K ﹤0.01%
33,614
+16,942
+102% +$47.1K

Similar funds

RhumbLine Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, RhumbLine Advisers held 4,391 positions worth $117B, up 9.2% from $107B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

RhumbLine Advisers's Q2 2025 filing shows 216 new, 2,182 increased, 1,537 reduced and 202 closed positions. Its largest new stake was Ralliant Corp: 320,982 shares worth $15.6M. The largest sale was Discover Financial Services, an estimated $91M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.

  • RhumbLine Advisers's largest Q2 2025 buy was Ralliant Corp: 320,982 shares worth $15.6M.
  • RhumbLine Advisers added most to Capital One in Q2 2025, an estimated $89.2M increase.
  • RhumbLine Advisers's biggest Q2 2025 reduction was iShares Russell 2000 ETF, cutting an estimated $75.5M.
  • RhumbLine Advisers fully exited Discover Financial Services in Q2 2025, selling an estimated $91M.
  • RhumbLine Advisers's ten largest holdings make up 31% of its $117B portfolio in Q2 2025.
  • RhumbLine Advisers opened 216 new positions and closed 202 in Q2 2025.
  • RhumbLine Advisers's portfolio value rose 9.2% quarter-over-quarter to $117B.

Based on RhumbLine Advisers's 13F filing for Q2 2025, filed 12 Aug 2025.